Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats - PubMed (original) (raw)
Comparative Study
Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats
Heidrun Potschka et al. Neuroreport. 2004.
Abstract
Multidrug transporter over-expression is considered to limit access of antiepileptic drugs to the epileptic focus region and to be one cause of intractable epilepsy. To reach further proof for this multidrug transporter hypothesis, we compared P-glycoprotein expression rates in subgroups of Wistar rats which are sensitive or resistant to the anticonvulsant effect of the antiepileptic drug phenytoin in the amygdala-kindling model of temporal lobe epilepsy. In the electrode-implanted amygdala of phenytoin-resistant rats, the area labelled for P-glycoprotein was more than twice as large than that in phenytoin-sensitive rats. The data indicate that P-glycoprotein expression levels in the kindled focus have a critical impact on the anticonvulsant response to antiepileptic drugs.
Similar articles
- Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats.
Seegers U, Potschka H, Löscher W. Seegers U, et al. Epilepsia. 2002 Jul;43(7):675-84. doi: 10.1046/j.1528-1157.2002.33101.x. Epilepsia. 2002. PMID: 12102668 - Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats.
Volk HA, Potschka H, Löscher W. Volk HA, et al. Epilepsy Res. 2004 Jan;58(1):67-79. doi: 10.1016/j.eplepsyres.2003.12.009. Epilepsy Res. 2004. PMID: 15066676 - Effect of phenytoin on sodium and calcium currents in hippocampal CA1 neurons of phenytoin-resistant kindled rats.
Jeub M, Beck H, Siep E, Rüschenschmidt C, Speckmann EJ, Ebert U, Potschka H, Freichel C, Reissmüller E, Löscher W. Jeub M, et al. Neuropharmacology. 2002 Jan;42(1):107-16. doi: 10.1016/s0028-3908(01)00148-4. Neuropharmacology. 2002. PMID: 11750920 - Animal models of drug-resistant epilepsy.
Löscher W. Löscher W. Novartis Found Symp. 2002;243:149-59; discussion 159-66, 180-5. Novartis Found Symp. 2002. PMID: 11990774 Review. - The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs.
Stępień KM, Tomaszewski M, Tomaszewska J, Czuczwar SJ. Stępień KM, et al. Pharmacol Rep. 2012;64(5):1011-9. doi: 10.1016/s1734-1140(12)70900-3. Pharmacol Rep. 2012. PMID: 23238460 Review.
Cited by
- Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
Löscher W, Potschka H. Löscher W, et al. NeuroRx. 2005 Jan;2(1):86-98. doi: 10.1602/neurorx.2.1.86. NeuroRx. 2005. PMID: 15717060 Free PMC article. Review. - The antiepileptic drug topiramate is a substrate for human P-glycoprotein but not multidrug resistance proteins.
Luna-Tortós C, Rambeck B, Jürgens UH, Löscher W. Luna-Tortós C, et al. Pharm Res. 2009 Nov;26(11):2464-70. doi: 10.1007/s11095-009-9961-8. Pharm Res. 2009. PMID: 19730994 - Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.
De Smedt T, Raedt R, Vonck K, Boon P. De Smedt T, et al. CNS Drug Rev. 2007 Spring;13(1):43-56. doi: 10.1111/j.1527-3458.2007.00004.x. CNS Drug Rev. 2007. PMID: 17461889 Free PMC article. Review. - A sensitive LC-MS/MS method for quantification of phenytoin and its major metabolite with application to in vivo investigations of intravenous and intranasal phenytoin delivery.
Prentice RN, Younus M, Rizwan SB. Prentice RN, et al. J Sep Sci. 2022 Jul;45(14):2529-2542. doi: 10.1002/jssc.202200025. Epub 2022 May 31. J Sep Sci. 2022. PMID: 35588117 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources